3 - 3 |
Age diversity in science Seijo BC |
4 - 4 |
Caution on red mud use Stamires D |
4 - 4 |
On regulations Sabatino CV |
4 - 4 |
On regulations Nyi K |
4 - 4 |
On regulations Kiser TK |
5 - 5 |
Route to cancer stem cell death ironed out Borman S |
6 - 6 |
Perovskite vulnerability uncovered Wilson E |
6 - 6 |
Electroplated batteries store more energy Bourzac K |
7 - 7 |
New role in cells suggested for ATP Kemsley J |
7 - 7 |
Stretchy material creates dynamic holograms Bourzac K |
8 - 8 |
Plant-derived compounds block sperm tail whipping Torrice M |
8 - 8 |
Hydrogens set a short-distance record Kemsley J |
8 - 9 |
'DNA slingshot' targets drug delivery Davenport M |
9 - 9 |
Nitrogen-based radical conquers challenging iodoalkane synthesis Ritter S |
9 - 9 |
A small-scale reactor for light-driven chemistry Halford B |
9 - 9 |
Artificial ovary restores fertility in mice Arnaud C |
12 - 12 |
AkzoNobel chemicals CEO eyes solo future Scott A |
12 - 12 |
Japanese firms reap benefits of closures Tremblay JF |
12 - 12 |
564 [Anonymous] |
13 - 13 |
Mood is bright at new drug ingredients show Mullin R |
13 - 13 |
Thermo Fisher to buy drug ingredients maker Patheon Reisch M |
14 - 14 |
Brazil approves DowDuPont deal Tullo A |
14 - 14 |
Laboratoire M2 raises $4.6 million Bomgardner M |
14 - 14 |
Firms pursue feed ingredients Bomgardner M |
14 - 14 |
GCP buys UK waterproofing firm Reisch M |
14 - 14 |
Honeywell starts up refrigerants plant Reisch M |
14 - 14 |
Daikin settles PFOA suit Reisch M |
14 - 14 |
Liveris will stay on longer at DowDuPont Tullo A |
15 - 15 |
SPECIALTY CHEMICALS Merck and FlexEnable shape the future Scott A |
15 - 15 |
DRUG DISCOVERY Vertex and X-Chem form library pact Mccoy M |
15 - 15 |
BIOTECHNOLOGY Synlogic goes public through merger Jarvis L |
15 - 15 |
Indian workers shut lights during FDA inspection Tremblay JF |
15 - 15 |
Boehringer starts plant, expands China R&D Tremblay JF |
16 - 16 |
Puerto Rican debt crisis hits chemists Widener A |
17 - 17 |
TRADE China agrees to review US biotech applications Hess G |
17 - 17 |
Faulty lead tests worry US regulators Erickson B |
18 - 20 |
THE LAB OF TODAY Gorder PF |
22 - 24 |
And now: The drug plant of the future Mullin R |
25 - 27 |
Thailand embarks on life sciences push Tremblay JF |
28 - 29 |
A tribute to alchemical oddities Everts S |
30 - 30 |
Chemical Safety Board faces death sentence Johnson J |
32 - 33 |
C&EN talks with Graham Hutchings, gold catalysis guru Peplow M |
36 - 38 |
SUMMER 2016 Learn everything, all at once [Anonymous] |
39 - 40 |
FALL 2017 Out of the lab, into the classroom [Anonymous] |
41 - 42 |
Back in the lab-this time, as the boss [Anonymous] |
43 - 45 |
SPRING 2017 The pressure to publish sets in [Anonymous] |
47 - 48 |
Reflecting on year one in 'the coolest job in the world' [Anonymous] |
51 - 51 |
In the room where it happens: Science and policy Pence LE |